Serena Group is a prominent entity in the field of wound care, focusing on advancing clinical research and innovative treatment solutions. The organization specializes in Hyperbaric Oxygen Therapy (HBOT), a state-of-the-art treatment that enhances the body's natural healing processes, making it a vital component in effective wound care management. By conducting rigorous clinical trials, Serena Group tests and validates new technologies and products aimed at improving patient outcomes, thereby establishing itself as a leader in the industry.

In addition to its clinical research initiatives, Serena Group emphasizes the importance of education and training for healthcare professionals. The company offers comprehensive educational services designed to equip clinicians with the latest knowledge and best practices in wound care. This commitment to empowering healthcare providers ensures that advancements in treatment and technology are effectively integrated into clinical practice, ultimately enhancing the quality of care delivered to patients. Through collaborative partnerships with industry leaders and academic institutions, Serena Group is dedicated to pioneering innovations that transform the landscape of wound care.

United States

We provide comprehensive treatment for acute and chronic wounds across all patient care settings, from the latest advances in chronic wound treatment and prevention to clinical research and hyperbaric medicine.

Serena Group

Company Details